INTRODUCTION AND OBJECTIVES: Sertoli cells thrive in an environment of high testosterone concentrations. Therefore, when subjected to low levels of testosterone, from any cause, abnormal spermatogenesis may occur. We performed a secondary analysis of a large, prospective clinical trial of couples with unexplained infertility to analyze whether sperm quality and pregnancy/live birth (LB) rates were associated with low total testosterone (TT).
INTRODUCTION AND OBJECTIVES: A severe male infertility factor has been associated with both lower health status and increased mortality in men from infertile couples. Little is known about the evolution of the health status in infertile men over time. We sought to inquire reproductive factors associated with health status decrease in infertile men METHODS: This is a cohort study enrolling 645 infertile men evaluated at baseline between 2003 and 2010. Infertility was defined according to the WHO definition. Health-significant comorbidities were scored with the Charlson Comorbidity Index (CCI). Patients were followed-up yearly recording any worsening in their health status until 2017. Cox regression models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) of CCI score increase including as covariates age, BMI, CCI, azoospermia, FSH, and duration of infertility.
RESULTS: Mean patient age was 37 years (interquartile range, IQR 34-40), median BMI 25 (IQR 23-27), 30 (5%) men had a CCI!1, and median duration of infertility was 24 months (IQR 13-30). Median follow-up was 9 years (IQR 7-11). 186 men (29%) saw an increase of their CCI score of at least 1 point. The most frequent reason for CCI upgrade was cancer, i.e. 43 solid tumors and 5 lymphomas. Compared to patients without a CCI increase, patients with a CCI increase had a higher proportion of CCI!1 (9% vs. 3%, p¼0.001) and a higher proportion of azoospermia (32% vs 20%, p¼0.001) at baseline. Azoospermic men had an increased risk of developing comorbidities at multivariable analysis (HR 1.88, 95% CI 1.31 -2.69; p¼0.001); along with a basal CCI!1 (HR 2.61, 95% CI 1.57 -4.36; p<0.001), and with a longer duration of infertility (HR 1.02, 95% CI 1.01-1.03; p¼0.008) azoospermic men were at higher risk of developing comorbidities during follow-up at multivariate analysis, after accounting for the aforementioned confounders CONCLUSIONS: At almost 10-years follow-up, a decrease of the overall health status is observed in a consistent proportion (29%) of infertile men, with most of them developing cancer. Azoospermic men (i.e. the most severe form of male infertility) showed the worst health status decrease, and should be strictly followed-up regardless of their fertility status The lack of clinicallyreliable biomarkers makes impossible to predict sperm retrieval outcomes at testicular sperm extraction (TESE) in men with non-obstructive azoospermia (NOA) undergoing in vitro fertilization programs, resulting in up to 50% of unnecessary surgical interventions. Aim of the study was to identify novel and user-friendly prognostic factors reliably predicting surgical outcomes in iNOA men in the real-life setting.
METHODS: Clinical data, hormonal profile and histological classification of testis parenchyma from 47 white-Caucasian idiopathic NOA (iNOA) men submitted to microdissection TESE (microTESE) were analyzed. Logistic regression analyses tested potential clinical predictors of positive sperm retrieval. The predictive accuracy of all variables was evaluated using the receiver operating characteristicderived area under the curve, and the clinical net benefit estimated by a decision-curve analysis (DCA).
RESULTS: Overall, 23 (49%) and 24 (51%) patients were classified as positive and negative sperm retrievals at microTESE. While circulating hormones associated to a condition of primary hypogonadism did not predict sperm retrieval, levels of anti-Mullerian hormone (AMH) and the ratio AMH-to-total Testosterone e796 THE JOURNAL OF UROLOGY â Vol. 199, No. 4S, Supplement, Sunday, May 20, 2018 
